-
Acadia Pharma to stop pimavanserin trials after failure
© Reuters. Acadia Pharma (ACAD) to stop pimavanserin trials after failure Shares of Acadia Pharma (ACAD) plunged Tuesday after the ... -
US Ukraine supporters advance effort to force House vote on aid
© Reuters. FILE PHOTO: A rescuer walks during a search operation for bodies under the rubble of a building destroyed ... -
Jefferies raises Kanzhun stock target to $23.30, maintains buy rating
© Reuters. On Tuesday, Jefferies, a global investment banking firm, increased its price target on shares of Kanzhun Ltd. (NASDAQ: ... -
JMP Securities boosts Ocular Therapeutix stock target to $24
© Reuters. On Tuesday, JMP Securities updated its outlook on Ocular Therapeutix (NASDAQ:), doubling the price target to $24.00 from ... -
Morgan Stanley cuts Sibanye-Stillwater stock target to ZAR 2000
© Reuters. On Tuesday, Morgan Stanley adjusted its stance on Sibanye-Stillwater (SGL:SJ) (NYSE: SBGL), reducing the mining company’s price target ... -
AST SpaceMobile updates ITU and FCC filings
© Reuters. MIDLAND, Texas – AST SpaceMobile, Inc. (NASDAQ: ASTS), which is developing a space-based cellular broadband network, has announced ... -
CytomX shares target cut to $3.25 from $3.25 by BMO Capital
© Reuters. Tuesday, BMO Capital Markets adjusted its price target on shares of CytomX Therapeutics (NASDAQ:), bringing it down to ... -
State-run Mexicana airline to buy 20 planes by October, says Lopez Obrador
© Reuters. FILE PHOTO: Mexico’s President Andres Manuel Lopez Obrador delivers a speech to present a package of constitutional reforms, ... -
Jefferies raises Casey’s General Stores stock target to $342 on strong earnings
© Reuters. On Tuesday, Jefferies updated its financial outlook for Casey’s General Stores (NASDAQ:), increasing its stock price target to ... -
Pro Research: Wall Street deep dive into Nike’s market dynamics
© Reuters. Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. ...
